FDA Approves Groundbreaking AI Tool to Predict Breast Cancer Risk
FDA Approves Groundbreaking AI Tool to Predict Breast Cancer Risk – In a landmark decision this spring, the U.S. Food and Drug Administration (FDA) granted its first-ever clearance for an artificial intelligence (AI)–based tool that estimates a woman’s five-year risk of developing breast cancer using only a standard screening mammogram. Developed by digital health company … Read more